Back to mobile site

Arena Pharma (ARNA) Gets PDUFA from U.S. FDA for Lorcaserin NDA

February 26, 2010 8:11 AM EST Send to a Friend
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login